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ABSTRACT 
Background: 
Majority of patients with unilateral hydronephrosis (HN) detected on ultrasound (US) 
do not require pyeloplasty. Indications for pyeloplasty are in patients with symptomatic 
obstruction (recurrent flank pain), complications such as urinary tract infection, a drop 
in differential renal function (DRF) of more than 10% and a progressive increase in the 
anterior posterior diameter (APD) in subsequent studies. Schlotmann et al, Piepsz et al 
and Harper et al have demonstrated the measurement of the cortical transit time (CTT) 
to predict the need for patient who may require pyeloplasty. 
Objectives:  
To assess if the CTT would have predicted a drop in DRF in patients with unilateral HN 
on the affected side. In addition to assess whether the CTT would differ on the first 
renogram between those patients who had a pyeloplasty and those who did not have a 
pyeloplasty at the Red Cross War Memorial Children’s Hospital (RCWMCH). 
Methods:  
Sixty eight (68) patients with at least two renograms with unilateral HN with a normal 
contralateral kidney were observed retrospectively between December 2000 and May 
2015. The CTT was recorded for the upper, middle and lower third of each kidney and 
the mean used as the CTT of the kidney. Each renogram was processed three times to 
measure the DRF using the Rutland Patlak and Integral methods. The mean of the three 
DRF measurements was used for analysis. 
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Results:  
The mean CTT of the left and right hydronephrotic kidneys were 6.0minutes and 
6.7minutes respectively. A significant relationship was demonstrated in the CTT and 
DRF as well as CTT and APD in the first renogram of those patients who did not have a 
pyeloplasty (p < 0.05). There was no difference between the DRF of the first and second 
renograms in those patients who did not have a pyeloplasty. 
In the 20 patients who had a pyeloplasty, there was a drop of more than 10% in the DRF 
of 3 patients. No difference was seen in the DRF or in the CTT between the first and 
second renogram. The CTT was shorter in the second renogram in 9 of the 20 patients 
who had a pyeloplasty. 
No significant difference was found in the CTT or DRF when comparing the group who 
had surgery against the group who did not have surgery. 
Conclusion:  
The current study was unable to demonstrate in our series of patients that CTT can 
predict those patients who would require pyeloplasty. This may be owing to the 
retrospective nature of the study and the reliance on the clinical notes for the US data 
and surgical notes. In future, a prospective study evaluating the relationship between 
CTT and a drop in the DRF should be undertaken in this unit. 
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Main manuscript  
Introduction 
In 2002, Josephson critically reviewed 6 patient series chosen on the basis of a diagnosis 
of antenatally detected hydronephrosis, compliance with defined criteria and 
publication during the 1990s to allow for a longer follow-up and better diagnostic tools. 
He found that 88-90% of patients with unilateral hydronephrosis (HN) detected 
antenatally do not require a pyeloplasty1. In the same year, Ulman et al2 reported that in 
their study population of 104 patients with antenatally detected severe unilateral HN, 
22% required surgical intervention to prevent loss of renal function. The generally 
accepted indications for pyeloplasty are symptomatic obstruction (recurrent flank 
pain), complications such as urinary tract infection, a decrease in Differential Renal 
Function (DRF) of more than 10%, and a progressive increase in the anterior posterior 
diameter (APD) in subsequent ultrasound (US) studies3. The accepted methods for 
calculation of the DRF in Technetium 99m mercaptoacetyltriglycine (99mTc MAG3) 
renography are the Rutland-Patlak (RP) and the integral methods. In the integral 
method, the DRF is calculated from the background corrected area under the renogram 
curve between 1- 2 minutes after injection of 99mTc MAG3. The DRF calculated by the RP 
plot method is estimated from the mean slope of the ascending portion of the curve 
plotting the background corrected kidney region of interest (ROI) counts divided the 
cardiac ROI counts as a function of the integral of the cardiac ROI counts divided by the 
cardiac ROI counts4. The size of the APD on US is used to classify the severity of HN and 
is a useful predictor for the resolution of HN5.  Accurate, repeated postnatal evaluation 
is therefore required to identify hydronephrotic kidneys that require surgical 
intervention. Recently, Schlotmann et al6, Piepsz et al7 and Harper et al8 have 
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demonstrated that the measurement of the cortical transit time (CTT) can be used to 
predict the need for pyeloplasty.  
The purpose of this retrospective study was to assess if the criteria used by Schlotmann 
et al6, Piepsz et al7 and Harper et al8 would have predicted a drop in DRF on the affected 
side. In addition, did the CTT differ on the first renogram  in patients who had a 
pyeloplasty and those who did not undergo surgery. Schlotmann et al6, Piepsz et al7 and 
Harper et al8 used the time of arrival of activity in the subcortical structures as a 
measure of the CTT.   
Method 
The Department of Nuclear Medicine at Red Cross War Memorial Children’s Hospital 
has a database in which all radiopharmaceutical doses, investigations done and reports 
are recorded and an electronic archive containing the raw data of all studies done since 
December 2000. 
 A database search was performed for patients who had at least two renograms between 
December 2000 and 31st August 2015. The hospital folders of these patients were then 
reviewed to confirm the diagnosis of unilateral HN with a normal contralateral kidney. 
A normal contralateral kidney was defined as a kidney with an APD < 10mm and normal 
corticomedullary differentiation on US. One hundred and seventy eight (178) patients 
were identified and 110 excluded; 105 did not have an US report in the clinical notes 
and 5 had an APD of less than 10mm, leaving 68 patients. 
 
All renograms were performed using 99mTc MAG3 (Mallinckrodt Medical), with the dose 
determined using the EANM dose card9, 10. Patients were hydrated IV prior to injection 
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of 99mTc MAG3 with 100 to 200mls of 0.9% NaCl solution. The F+20 protocol was used 
as recommended in the Guidelines for standard and diuretic renogram in children4,11, 
with 1.0mg/kg furosemide being administrated up to a maximum of 20mg. 
The raw data was acquired with a Philips Axis Dual Head camera (Picker International 
Inc., Cleveland, Ohio, USA) with a low energy high resolution (LEHR) collimator on a 
128 x 128 matrix. The duration of the renogram was 42 minutes: 1s/frame for the first 
2 minutes, 15 second/frame for 40 minutes. The child was then held erect or stood up 
for 5 minutes after which a static post micturition post gravity drainage image was 
acquired for 5 minutes.  
The raw data was retrieved from the electronic archive and reprocessed. The visual 
procedure described by Piepsz et al7 was used to determine CTT. The time of arrival of 
activity in the subcortical structures, calyces of the upper, middle and lower third of 
each kidney and pelvis were recorded. The mean of the times activity appeared in the 
calyces was used as the CTT of the kidney. Each renogram was processed three times on 
the HERMES Gold TM software package to measure the DRF using the RP and Integral 
methods4, 11. The mean of the three DRF measurements was used for analysis. 
 
The study was approved from the Human Research Ethics Committee of the University 
of Cape Town (HREC Reference no 839/2015, see approval in appendix IV). 
 
Statistical analysis 
Statistical analysis was performed using the Stata software package (StataCorp. 
2011. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP). The 
Shapiro Wilks test was used to test distribution. The median, 25th and 75th centiles, and 
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minimum and maximum were used as descriptive statistics. The Wilcoxon signed rank 
test was used for paired data and the Mann Whitney U test to compare groups. 
Spearman rank correlation test used to assess the association between variables. 
Results 
Patient demographics 
Of the 68 patients with unilateral HN and a normal contralateral kidney, 43 were male 
and 25 were female. The median age at presentation for the initial renogram was 2.2 
months (range 0.2 – 115.3months). Thirty six (36) had left sided HN, with a median CTT 
of 6 minutes and 32 right sided HN with a median CTT of 6.7 minutes on the initial 
renogram. The median APD of the left and right HN kidneys were 18.3mm and 23mm 
respectively (Tables 1 and 2).  
Comparing DRF and CTT in the patients who did not have a pyeloplasty 
Table 3 summarises the DRF and CTT in the normal contralateral kidneys and the left 
and right HN kidneys of the 48 patients who did not have a pyeloplasty. There was no 
difference between DRF of the first and second renograms (z = -0.858, p >0.05, n=47; in 
the first renogram of one child, the left hydronephrotic kidney extended to the body 
outline, making it impossible to draw the standard regions of interest used to calculate 
DRF). In five patients, there was a drop of more than 10% in the DRF but no record of 
the reasons for not doing a pyeloplasty. The ages of these patients ranged between 0.1 – 
43.2 months, and the APDs ranged between 11.4 and 40mm. In the first renogram, the 
longest CTT in a normal kidney was 3 minutes, while the shortest CTT in a 
hydronephrotic kidney was 3.7 minutes. In 32 of the 48 patients, the second renogram 
showed a decrease in CTT with the CTT of one hydronephrotic kidney falling into the 
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range of the CTT of normal kidneys. The change in the CTT of the first and second 
renograms was significant (z = 4.029, p <0.0001). Figure 1 illustrates the relationship 
between the CTT and DRF in the first renogram of the patients who did not have a 
pyeloplasty (ρ= -0.2731, p <0.05) and Figure 2 the relationship between CTT and APD 
(ρ= 0.2864, p < 0.05) 
Comparing DRF and CTT in the patients who had a pyeloplasty 
In the 20 patients who had a pyeloplasty, there was a drop of more than 10% in the DRF 
of three patients. No difference was seen in the DRF (z = 0.355, p >0.05) or in the CTT 
(z=1.217, p>0.05) between the first and second renogram. CTT was shorter in the 
second renogram in nine of the 20 patients who had a pyeloplasty. 
No significant difference was found in the CTT (z = -0.054, p >0.05) or DRF (z = 0.452, p 
>0.05) when comparing the group who had surgery against the group who did not have 
surgery. 
Data of pyeloplasty group compared to the control group 
The indication for doing or not doing a pyeloplasty was not clearly stated in the clinical 
notes of every patient so we undertook a supplementary analysis in those patients who 
had a pyeloplasty. Each of the children who had a pyeloplasty was matched with a child 
who did not have surgery based on age within a month and APD within two standard 
deviations from the median of the APD of the patients who had surgery. The control 
group was selected from the 48 patient who did not undergo pyeloplasty. Fifteen (15) of 
the patients were male and five (5) were female with a median age of 1.9 months (range 
0.2 – 86.4 months). Twelve (12) had left sided HN, with a median CTT of 6.3 minutes 
and eight(8) right sided HN with a median CTT of 6.5 minutes. The median APD of the 
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left and right HN kidneys were 21.6mm and 25mm respectively. The results of the 
control group are presented in Table 4. 
The median interval between the initial renogram and pyeloplasty was 2.7 months 
(range 0.2 – 72 months) and the median interval between the first and second 
renogram was 5.2 months (range 0.46 – 22.2months). The pyeloplasty was performed 
between the first and second renogram. In the control group, the median interval 
between the first and second renogram was 4.4 months (range 0.1 – 31.8 months). 
Table 5 presents the CTT and DRF of the pyeloplasty group and the control group. There 
was no difference in CTT (z = -0.027, p>0.05) or DRF (z = -1.799, p>0.05) on the first 
renogram but a deterioration in DRF of more than 10 % was seen in three patients on 
their post pyeloplasty renogram. Figure 3 illustrates the relationship between the CTT 
(ρ= 0.3418, p >0.05) and DRF (ρ= 0.0950, p >0.05). 
Discussion 
The mean CTT of the left and right hydronephrotic kidneys were 6.0 minutes and 
6.7 minutes respectively. An inverse relationship was demonstrated between CTT and 
DRF in the first renogram of patients who did not have a pyeloplasty. In these patients, 
patients with prolonged CTT had a larger APD. 
There was no difference between the DRF of the first and second renograms in those 
patients who did not have a pyeloplasty. In the 20 patients who had a pyeloplasty, there 
was a drop of more than 10% in the DRF of three patients. No difference was seen in the 
DRF or in the CTT between the first and second renogram. The CTT was shorter in the 
second renogram in nine of the 20 patients who had a pyeloplasty. No significant 
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difference was found in the CTT or DRF when comparing the group who had surgery 
against the group who did not have surgery.  
Most children with an antenatal diagnosis of HN do not require surgical intervention1, 2. 
Those likely to benefit from a pyeloplasty are usually symptomatic11 or identified using 
an imaging modality. Currently the most widely used practice is serial imaging with US 
and diuretic renography to detect the earliest signs of a progression in the HN or 
deterioration in the DRF12.  
Several reports have described the use of CTT to predict deterioration in the function of 
the hydronephrotic kidney6-8, 13, 14, 15. The use of this parameter stems from the 
postulate that in an obstructed kidney, there is an increase in the pelvic pressure which 
will lead to a decrease in the renal blood flow, thereby a decrease in the glomerular 
filtration rate16. This ultimately leads to activation of the renin angiotensin system with 
a series of events which leads to sclerosis. Sclerosis is a very late event in renal outflow 
obstruction. Increased intrarenal pressure from PUJ obstruction is enough to impair 
GFR and lead to prolongation of CTT. Therefore, the effect is decreased washout of 
radiotracer from the renal parenchyma on scintigraphy6, 16. 
The studies performed by Schlotmann et al6, Piepsz et al7 and Harper et al8 all 
demonstrated the feasibility of using the time of arrival of activity in the subcortical 
structures as an index for CTT to predict the kidneys which would benefit from surgical 
intervention. Neither Schlotmann nor Harper report the time of appearance of activity 
in the subcortical structures in normal or hydronephrotic kidneys. They only state that 
the time of appearance of activity in the hydronephrotic kidneys was abnormal. The 
CTTs in the HN kidneys in our study were comparable to those in Piepsz’s study (3 – 8 
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minutes) 7. In our patients, the CTT of each hydronephrotic kidney was longer than the 
CTT of the normal contralateral kidney on the first renogram.  
In our patients, there was a significant change in CTT between the first and second 
renogram in those patients who did not have a pyeloplasty. Thirty two (32) of the 48 
patients showed a drop in the CTT between the first and second renogram. This is in 
contrast with Harper and Schlotmann’s groups, where Harper et al8 only identified two 
patients with abnormal CTT who did not have surgery. One patient had an improvement 
in their CTT, and the other had a deterioration in their CTT. It is not stated whether this 
patient had further intervention. Schlotmann et al6 identified three of 14 patients with 
abnormal CTT who had no surgery of which two deteriorated and one remained stable. 
The change in the CTT was not reported in Piepsz’ group7 between the first and second 
renogram. 
There was no significant change in DRF between the first and second renogram in our 
patients who did not have a pyeloplasty. A drop of more than 10% in the DRF between 
the first and second renogram was seen in five, a frequency consistent with Josephson1. 
Despite the fact that a drop in DRF of more than 10% in subsequent studies is an 
acceptable criterion for a pyeloplasty, the CTT did not identify these patients who may 
have qualified for surgery. In the ten patients who had no surgery in Piepsz’s group7, 
four had a deterioration in their DRF, with the remaining six patients having no 
deterioration in DRF. 
We were also able to assess if there was a significant difference in the CTT and DRF in 
the group of patients who had a pyeloplasty and compare them to the patients who did 
not have surgery as well as a control group. This was not demonstrated in our study. 
Three patients were identified who had a deterioration in DRF of more than 10 % on 
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their post pyeloplasty renogram. We were unable to identify reasons for this 
deterioration from the clinical records. In comparison, Harper et al8 showed an 
improvement in CTT post pyeloplasty (however this was not quantified); Schlotmann et 
al6 demonstrated in eight out of 13 an improvement in the CTT post-surgery. Piepsz et 
al7 demonstrated in ten of the 16 patients who had surgery had an improvement in the 
DRF. The remainder of the patients showed no significant change in DRF. 
 
Limitations of the study 
One of the limitations of this study was that it was retrospective, relying on the standard 
hospital record system to access data relating to the US information and notes on 
surgery. There was missing data in terms of the US reports and the indications for the 
pyeloplasty and reasons for not doing a pyeloplasty were not clearly recorded in some 
of the notes. 
 
Conclusion 
The current study was unable to demonstrate in our series of patients that CTT can 
predict those patients who would require pyeloplasty. As stated previously, this may be 
owing to our study being retrospective and our reliance on the clinical notes for the US 
data and surgical notes. 
In future, a prospective study evaluating the relationship between CTT and a drop in the 
DRF should be undertaken in this unit. 
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TABLES 
 
Table 1 Summary of data of all patients 
Sex Male  43 
 Female 25 
Time between initial and 
second renogram 
(months) 
Median 4.9 
Age (months) Median 2.2 
 Range 0.24 – 115.3 
Affected sides Left 36 
 Right 32 
Ultrasound data   
 Left  side  
APD(mm) Median 18.3 
 Range 10 – 57 
 Right  side  
APD(mm) Median 23 
 Range 10 – 69.7 
Cortical Transit 
Time(minutes) 
  
  Renogram1 Renogram2 
Left side Median 6.0 5.3 
Right side Median 6.7 5.7 
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Table 2 Summary of data of 48 patients who did not have a pyeloplasty 
Affected sides Left 24 
 Right 24 
Ultrasound data   
 Left  side  
APD(mm) Median 17 
 Range 10 – 40 
 Right side  
APD(mm) Median 21.9 
 Range 10 – 69.7 
Cortical Transit 
Time(minutes) 
  
  Renogram1 Renogram2 
Left side Median 6.0 5.0 
Right side Median 6.7 5.7 
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Table 3. CTT and DRF of the normal contralateral left hydronephrotic and right hydronephrotic kidneys of the patients who 
did not have a pyeloplasty 
 Median Interquartile range Minimum Maximum 
  25 75  
 *R1 *R2 R1 R2 R1 R2 R1 R2 R1 R2 
Normal contralateral 
kidney 
 
Left CTT (minutes) 2 2 2 2 3 
Right CTT (minutes) 2 2 2.5 2.7 2 3 
 
Left Hydronephrotic  
CTT (minutes) 6 5.0 4.0 3.8 7.0 7.0 3.7 3.0 10 10 
DRF (%) 49 47 42 37 53 51 28 3 63 62 
Right Hydronephrotic  
CTT (minutes) 6.7 5.7 6.0 4.5 9.5 6.7 4.0 2.0 10 8.3 
DRF (%) 42 45 34 33 51 51 1 9 56 56 
*R1 – renogram 1 
R2 – renogram 2 
Please note that the DRF calculations were performed on 47 patients. 
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Table 4 Summary of data of 20 patients who had a pyeloplasty and the control 
group  
 Pyeloplasty 
group  
Control group  
Sex Male  12 14 
 Female 8 6 
Age (months) Median 1.6 2.2 
 Range 0.2-86.4 0.7-77.9 
Affected sides Left 12 13 
 Right 8 7 
Ultrasound data    
 All   
APD(mm) Median 24 21.4 
 Range 12 - 57 10-46 
 Right  side   
               APD(mm) Median 25 19 
 Range 14 - 50 11.5-46 
 Left side   
APD(mm) Median 21.6 24 
 Range 12 - 57 10-39 
Cortical Transit 
Time 
   
Left side Median 5.8 6.0 
Right side Median 6.5 7.3 
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Table 5 Quantitative Data relating to the patients who had surgery against the 
patients who are part of the control group comparing CTT and DRF 
 Median Interquartile range Minimum Maximum 
  25 75  
 *R1 *R2 R1 R2 R1 R2 R1 R2 R1 R2 
Pyeloplasty patients  
CTT (minutes) 6.3 5.5 5.0 4.7 7.8 7.0 4.0 4.0 10.0 10.0 
DRF (%) 46 44 41 32 50 49 18 16 56 57 
Control group  
CTT (minutes) 6.3 4.7 5.5 3.8 7.5 6.3 4.0 3.0 10.0 8.3 
DRF (%) 50 49 46 42 53 52 29 12 63 58 
*R1 – renogram 1 
R2 – renogram 2 
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FIGURES 
 
 
Fig1: CTT vs DRF in those kidneys which did not have a pyeloplasty 
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Fig2: CTT vs APD in kidneys which did not have a pyeloplasty 
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Figure 3: CTT vs DRF: Pyeloplasty group vs control group 
 
 
 
 
 
 
 
 
 
APPENDIX I: RESEARCH PROTOCOL 
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This research protocol was submitted to the Faculty of Health Sciences, University of 
Cape Town before commencement of the study. 
Title of Study: 
Renal cortical transit time as a predictor for pyeloplasty in paediatric patients with 
unilateral hydronephrosis. 
 
Background: 
Hydronephrosis (HN) is defined as dilatation of the renal collecting system regardless of 
the aetiology.  The majority of cases which are detected antenatally are asymptomatic 
and generally will not require any surgical intervention. This was shown in a critical 
review by Josephson, who found that 88% of those cases who had unilateral HN 
detected antenatally did not require any urological surgical intervention1. The causes of 
HN that may require intervention are varied, with pelvi-ureteric junction (PUJ) 
obstruction being the most common, closely followed by vesicoureteral reflux (VUR), 
obstructive mega ureter and ureterocoele2.   
Literature Review: 
According to a definition by Koff, obstruction to a kidney is defined as "any impairment 
of renal outflow that, left untreated, would lead to a loss of renal function or would 
prevent the normal maturation of renal function”. 
This definition of obstruction is retrospective as it is based on a deterioration of the 
differential renal function (DRF) 3.  
In those patients who would require urological surgical intervention owing to PUJ 
obstruction, a pyeloplasty is the procedure of choice. 
 
A pyeloplasty is a surgical procedure which provides dependent drainage of urine from 
the hydronephrotic kidney.  Factors which are strongly considered for pyeloplasty are 
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in those patients with symptomatic obstruction (that being recurrent flank pain), a 
decrease of split function of more than 10% in subsequent studies and complications 
such as urinary tract infections. Other parameters such as impaired split function 
(<40%), grade III/IV renal pelvic dilatation with associated parenchymal thinning (as 
defined by the Society for Fetal Urology) and poor drainage of tracer after the 
administration of furosemide are considered to a lesser extent in determining which 
patients will benefit from a pyeloplasty4. 
 
The prolonged tissue tracer transit time (also called the cortical transit time(CTT)) of  
99mTc MAG3 was reviewed by Schlotmann in an initial study in which he demonstrated 
on animal models that a delay in CTT accompanied a decline in  renal function and 
associated histomorphological changes in those animal models with unilateral HN5.  
 
This concept was then applied by Schlotmann to a series of patients who had unilateral 
HN with a normal contralateral kidney detected on US. One hundred and fifteen (115) 
patients were part of the sample analysed. Twelve percent of the 115 patients (which 
equated to 14 patients) in Schlotmann’s study were identified as having delayed cortical 
transit time. Of the 14 patients in this study, 10 of them required surgery in order to 
prevent further decline. Eight (8) of these patients then improved post-surgical 
intervention. This demonstrated that kidneys with delayed cortical transit do have the 
ability to improve after therapy. The CTT can be used as a predictor for those patients 
who will require surgical intervention in order to preserve the function of a unilateral 
hydronephrotic kidney (in those patients who had a normal contralateral kidney) 6.  
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Piepsz and colleagues aimed to verify Schlotmann’s statement of CTT having a 
predictive role in predicting functional impairment. They found that the cortical transit 
was a valuable tool in identifying those patients who could benefit from a pyeloplasty, 
with 10 out of 16 patients showing a significant improvement in the DRF post 
pyeloplasty7. 
 
Another group, Harper and colleagues, reviewed both Schlotmann’s and Piepsz’s work 
to ascertain whether an initial measurement of the CTT correlated significantly with the 
need for surgery.  Thirty seven (37) patients were identified with unilateral HN with a 
pelvic diameter of 12mm and Piepsz’s model was applied to assess CTT. This was 
defined as absence of activity in the subcortical structures within 3 minutes of tracer 
injection7. Of the 22 patients identified with delayed CTT, 20 of these patients 
underwent surgery. Harper and colleagues found that the CTT could be used as a 
reliable prognostic factor in order to map out the future evolution of renal function in 
those children with HN8. 
 
A visual assessment tool was used to quantify CTT in all of the above studies. The reason 
for using a visual assessment tool is twofold. Firstly, methods currently used to quantify 
CTT, namely deconvolution tools, parametric images which use pixel by pixel time to 
maximum, mean transit time and factor analysis are not able to differentiate delayed 
CTT from stasis in the case of an overlapping collecting system. Secondly, the movement 
of children may impact on the quality of the study and falsely give impression of normal 
transit especially in the periphery of the kidneys7, 9.  
 
Objectives: 
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1) Does the time of arrival of activity in the subcortical structures after tracer 
injection predict a drop in DRF on the affected side in patients with unilateral 
HN? 
 
2) Does the visual assessment of CTT in children who went on to have pyeloplasty 
due to a drop in DRF differ significantly from age and renal pelvis size matched 
controls? 
Methods: 
Study Design: 
This will be a retrospective study 
Patient selection: 
The raw data of all renograms performed in the Nuclear Medicine Department at 
RCWMCH is stored in an electronic database and available for review. All clinical 
information is stored in a separate database and the names of all patients who had 
renogram(s) in our department from the 1st of December 2000 will be retrieved. 
The inclusion criteria for the first question are: 
 Patients with unilateral HN detected on ultrasound with a normal contralateral 
kidney  
 Patients with at least two renograms.  
Exclusion criteria: 
 Renograms performed for  indications other than PUJ syndrome 
 Patients with bilateral HN 
 Patients with solitary kidneys 
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 Patients with ectopic kidneys 
Patient selection for the second question: 
1. All children who went on to have a pyeloplasty will be included; the indication 
for the pyeloplasty will be recorded. 
2. Patients who went on to have a pyeloplasty will be matched to the first patient in 
the database with matching age and renal AP diameters. 
The CTT renal pelvic size matched controls will be based on the anatomical definitions 
as prescribed by the Society of Foetal Urology10.  
 
Measurement: 
The CTT of the renogram will be assessed visually as described by Piepsz7.  
One minute summed images for the first ten minutes of each study will be evaluated for 
the appearance of activity in the “calyces”. 
The DRFs of the study patients will be calculated according to the Patlak-Rutland plot 
method and integral methods11. 
 
Ethical considerations: 
No patient names will be revealed in any document.  The scans performed were part of 
standard diagnostic tests on each patient which are all in accordance with published 
international guidelines. All data would be handled in a completely confidential and 
ethical manner according to the Helsinki Declaration12. 
 
The study will not affect the running of the Nuclear Medicine, Paediatric Urology or 
Paediatric Nephrology departments at the hospital. 
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There are no financial implications for the hospital12.  
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APPENDIX IV: DATA SHEETS 
Data Sheet  
Folder number: __________________ 
Date of Scan: ____________________ 
Time of renogram commencement: ________ 
Time of post micturition image: ____________ 
Date of Birth: ____________________ 
Age at Scan: _____________________ 
Weight: ___________ height: ______________ 
Technical: Include study: Yes/No 
If no, state reason: _____________________________ 
Lasix administered: Yes/No _____ Affected side: _________________________________ 
   Right kidney Left kidney 
A
. 
Differential 
Renal Function 
(%) 
Rutland Patlak       
Integral       
NORA       
ROE (%) At 20 min       
At 40 min       
T half       
 
B Date of 
Ultrasound 
 
 
 
   
AP Pelvic diameter (mm)   
Status of bladder( full/empty)   
 Cortical thinning   
  
   uppe
r 
middl
e 
lowe
r 
uppe
r 
middl
e 
Lowe
r 
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C Time  and 
location of  
visualisation of 
activity in the 
subcortical 
structures 
(minutes) 
Indicate with a 
tick and 
description if 
necessary 
1 – 2   
 
2 – 3   
 
3 – 4   
 
4 – 5   
 
5 – 6   
 
6 – 7   
 
7 – 8   
 
8 – 9   
 
9 – 10   
 
>10   
 
 Visualisation of 
bladder activity 
(min) 
   
 Visualisation of 
ureter(min) 
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D     
Micturition 
during the 
renogram 
Yes/no  
Time of 
micturition(mi
n) 
  
Status of 
bladder and 
kidney at the 
end of the 
renogram 
Kidney(marke
d 
/moderate 
/minimal 
parenchymal 
activity) 
 
 Bladder  
Post 
Micturition 
recorded 
Yes/No   
Kidney counts 
at 
2 min   
Adequate 
drainage 
Second last 
summed 
minute image 
of renogram 
  
  Second last 
image post 
micturition 
  
 
NORA – normalised residual activity  
ROE – renal output efficiency 
AP – anterior posterior 
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APPENDIX V: SOUTH AFRICAN JOURNAL OF SURGERY AUTHOR GUIDELINES  
Author Guidelines 
Accepted manuscripts that are not in the correct format specified in these 
guidelines will be returned to the author(s) for correction, and will delay 
publication.  
AUTHORSHIP  
Named authors must consent to publication. Authorship should be based on substantial 
contribution to: 
(i) conception, design, analysis and interpretation of data; 
(ii) drafting or critical revision for important intellectual content; and 
(iii) approval of the version to be published. These conditions must all be met (uniform 
requirements for manuscripts submitted to biomedical journals; refer 
to www.icmje.org).  
CONFLICT OF INTEREST  
Authors must declare all sources of support for the research and any association with a 
product or subject that may constitute conflict of interest.  
RESEARCH ETHICS COMMITTEE APPROVAL  
Provide evidence of Research Ethics Committee approval of the research where 
relevant.  
PROTECTION OF PATIENT'S RIGHTS TO PRIVACY  
Identifying information should not be published in written descriptions, photographs, 
and pedigrees unless the information is essential for scientific purposes and the patient 
(or parent or guardian) gives informed written consent for publication. The patient 
should be shown the manuscript to be published. Refer to www.icmje.org.  
ETHNIC CLASSIFICATION References to ethnic classification must indicate the 
rationale for this.  
MANUSCRIPTS Shorter items are more likely to be accepted for publication, owing to 
space constraints and reader preferences.  
Original articles not exceeding 3 000 words, with up to 6 tables or illustrations, are 
usually observations or research of relevance to surgery. References should preferably 
be limited to no more than 15. Please provide a structured abstract not exceeding 250 
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words, with the following recommended headings: Background, Objectives, Methods, 
Results, and Conclusion.  
Scientific letters/short reports, which include case reports, side effects of drugs and 
brief or negative research findings should preferably be 1500 words or less, with 1 table 
or illustration and no more than 6 references. Please provide an accompanying abstract 
not exceeding 150 words.  
Editorials, Opinions, etc. should be about 1000 words and are welcome, but unless 
invited, will be subjected to the SAJS peer review process.  
Review articles are rarely accepted unless invited.  
Letters to the editor, for publication, should be about 400 words with only one 
illustration or table, and must include a correspondence address.  
Obituaries should be about 400 words and may be accompanied by a photograph.  
MANUSCRIPT PREPARATION Refer to articles in recent issues for the presentation of 
headings and subheadings. If in doubt, refer to 'uniform requirements' 
- www.icmje.org. Manuscripts must be provided in UK English.  
Qualification, affiliation and contact details of ALL authors must be provided in the 
manuscript and in the online submission process.  
Abbreviations should be spelt out when first used and thereafter used consistently, e.g. 
'intravenous (IV)' or 'Department of Health (DoH)'.  
Scientific measurements must be expressed in SI units except: blood pressure 
(mmHg) and haemoglobin (g/dl). Litres is denoted with a lowercase 'l' e.g. 'ml' for 
millilitres). Units should be preceded by a space (except for %), e.g. '40 kg' and '20 cm' 
but '50%'. Greater/smaller than signs (> and 40 years of age'. The same applies to ± and 
º, i.e. '35±6' and '19ºC'.  
Numbers should be written as grouped per thousand-units, i.e. 4 000, 22 160...  
Quotes should be placed in single quotation marks: i.e. The respondent stated: '...' 
Round brackets (parentheses) should be used, as opposed to square brackets, which 
are reserved for denoting concentrations or insertions in direct quotes.  
General formatting The manuscript must be in Microsoft Word or RTF document 
format. Text must be single-spaced, in 12-point Times New Roman font, and contain no 
unnecessary formatting (such as text in boxes, with the exception of Tables).  
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ILLUSTRATIONS AND TABLES If tables or illustrations submitted have been published 
elsewhere, the author(s) should provide consent to republication obtained from the 
copyright holder.  
Tables may be embedded in the manuscript file or provided as 'supplementary files'. 
They must be numbered in Arabic numerals (1,2,3...) and referred to consecutively in 
the text (e.g. 'Table 1'). Tables should be constructed carefully and simply for intelligible 
data representation. Unnecessarily complicated tables are strongly discouraged. Tables 
must be cell-based (i.e. not constructed with text boxes or tabs), and accompanied by a 
concise title and column headings. Footnotes must be indicated with consecutive use of 
the following symbols: * † ‡ § ¶ || then ** †† ‡‡ etc.  
Figures must be numbered in Arabic numerals and referred to in the text e.g. '(Fig. 1)'. 
Figure legends: Fig. 1. 'Title...' All illustrations/figures/graphs must be of high 
resolution/quality: 300 dpi or more is preferable but images must not be resized to 
increase resolution. Unformatted and uncompressed images must be attached as 
'supplementary files' upon submission (not embedded in the accompanying 
manuscript). TIFF and PNG formats are preferable; JPEG and PDF formats are accepted, 
but authors must be wary of image compression. Illustrations and graphs prepared in 
Microsoft Powerpoint or Excel must be accompanied by the original workbook.  
REFERENCES Authors must verify references from the original sources. Only complete, 
correctly formatted reference lists will be accepted. Reference lists must be generated 
manually and not with the use of reference manager software. Citations should be 
inserted in the text as superscript numbers between square brackets, e.g. These 
regulations are endorsed by the World Health Organization,[2] and others.[3,4-6] All 
references should be listed at the end of the article in numerical order of appearance in 
the Vancouver style (not alphabetical order). Approved abbreviations of journal titles 
must be used; see the List of Journals in Index Medicus. Names and initials of all authors 
should be given; if there are more than six authors, the first three names should be 
given followed by et al. First and last page, volume and issue numbers should be 
given. Wherever possible, references must be accompanied by a digital object 
identifier (DOI) link and PubMed ID (PMID)/PubMed Central ID (PMCID). Authors 
are encouraged to use the DOI lookup service offered by CrossRef.  
Journal references: Price NC, Jacobs NN, Roberts DA, et al. Importance of asking about 
glaucoma. Stat Med 1998;289(1):350-355. [http://dx.doi.org/10.1000/hgjr.182] [PMID: 
2764753]  
Book references: Jeffcoate N. Principles of Gynaecology. 4th ed. London: Butterworth, 
1975:96-101. Chapter/section in a book: Weinstein L, Swartz MN. Pathogenic Properties 
of Invading Microorganisms. In: Sodeman WA jun, Sodeman WA, eds. Pathologic 
Physiology: Mechanisms of Disease. Philadelphia: WB Saunders, 1974:457-472.  
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Reducing Risks, Promoting Healthy Life. Geneva: World Health Organization, 2002. 
http://www.who.int/whr/2002 (accessed 16 January 2010).  
Other references (e.g. reports) should follow the same format: Author(s). Title. 
Publisher place: publisher name, year; pages. Cited manuscripts that have been 
accepted but not yet published can be included as references followed by '(in press)'. 
Unpublished observations and personal communications in the text must not appear in 
the reference list. The full name of the source person must be provided for personal 
communications e.g. '...(Prof. Michael Jones, personal communication)'.  
PROOFS A PDF proof of an article may be sent to the corresponding author before 
publication to resolve remaining queries. At that stage, only typographical changes are 
permitted; the corresponding author is required, having conferred with his/her co-
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